Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Atopic Dermatitis Excellence Forum

Amy S. Paller, MD
Q&As
06/07/2023
Jessica Garlewicz, Digital Managing Editor
In this exclusive interview with The Dermatologist, Dr Amy Paller discussed how atopic dermatitis severity affects fatigue in children.
In this exclusive interview with The Dermatologist, Dr Amy Paller discussed how atopic dermatitis severity affects fatigue in children.
In this exclusive interview with...
06/07/2023
The Dermatologist
Amy S Paller, MD
Videos
04/27/2023
Dr Amy Paller discusses how atopic dermatitis severity affects fatigue in children and how physicians can take a proactive approach.
Dr Amy Paller discusses how atopic dermatitis severity affects fatigue in children and how physicians can take a proactive approach.
Dr Amy Paller discusses how...
04/27/2023
The Dermatologist
Maria Schneeweiss, MD
Videos
02/22/2023
Jessica Garlewicz, Digital Managing Editor
Dr Maria Schneeweiss shared insights into her study on patterns when using systemic immunomodulators before and after dupilumab approval when treating adults with atopic dermatitis.
Dr Maria Schneeweiss shared insights into her study on patterns when using systemic immunomodulators before and after dupilumab approval when treating adults with atopic dermatitis.
Dr Maria Schneeweiss shared...
02/22/2023
The Dermatologist
Maria Schneeweiss, MD
Q&As
01/30/2023
Jessica Garlewicz, Digital Managing Editor
The Dermatologist met with Dr Maria Schneeweiss to discuss her recent study on the patterns when using systemic immunomodulators in the United States before and after dupilumab approval when treating adults with atopic dermatitis.
The Dermatologist met with Dr Maria Schneeweiss to discuss her recent study on the patterns when using systemic immunomodulators in the United States before and after dupilumab approval when treating adults with atopic dermatitis.
The Dermatologist met with Dr...
01/30/2023
The Dermatologist
Elisha Myers
Q&As
12/08/2022
Jessica Garlewicz, Associate Digital Editor
In this feature interview, The Dermatologist met with Elisha Myers to discuss her recent study.
In this feature interview, The Dermatologist met with Elisha Myers to discuss her recent study.
In this feature interview, The...
12/08/2022
The Dermatologist
Elisha Myers is a member of the Center for Dermatology Research in the department of dermatology at the Wake Forest School of Medicine in Winston-Salem, NC.
Videos
11/23/2022
In this video interview, Elisha Myers discusses how physicians can take a multifaceted approach to atopic dermatitis treatment that reduces costs.
In this video interview, Elisha Myers discusses how physicians can take a multifaceted approach to atopic dermatitis treatment that reduces costs.
In this video interview, Elisha...
11/23/2022
The Dermatologist
Clinical Insights
10/18/2022
Jessica Garlewicz, Associate Digital Editor
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved...
10/18/2022
The Dermatologist
Dr Cathal O'Connor on Burden of Treatment in Patients With Atopic Dermatitis
Videos
08/18/2022
In this interview, Cathal O’Connor, MD, addresses the burden of treatment in adult patients with atopic dermatitis, including its effect on the decision-making process for dermatologists and patients’ quality of life.
In this interview, Cathal O’Connor, MD, addresses the burden of treatment in adult patients with atopic dermatitis, including its effect on the decision-making process for dermatologists and patients’ quality of life.
In this interview, Cathal...
08/18/2022
The Dermatologist
Clinical Insights
08/16/2022
Amanda Balbi, Associate Director, Digital Content
Eye involvement is common in patients with moderate to severe atopic dermatitis.
Eye involvement is common in patients with moderate to severe atopic dermatitis.
Eye involvement is common in...
08/16/2022
The Dermatologist
Dr Mercedes Gonzalez
Q&As
07/21/2022
Jessica Garlewicz, Associate Digital Editor
The Dermatologist met with Mercedes Gonzalez, MD, an investigator in the randomized, placebo-controlled pivotal trial, to discuss dupilumab's recent approval.
The Dermatologist met with Mercedes Gonzalez, MD, an investigator in the randomized, placebo-controlled pivotal trial, to discuss dupilumab's recent approval.
The Dermatologist met with...
07/21/2022
The Dermatologist

Advertisement

Advertisement

Advertisement